{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:05:11Z","timestamp":1792757111393,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","award":["R21HL145217"],"award-info":[{"award-number":["R21HL145217"]}],"id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","award":["R01 NR013396"],"award-info":[{"award-number":["R01 NR013396"]}],"id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","award":["U19AG063893"],"award-info":[{"award-number":["U19AG063893"]}],"id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","award":["DZHK\/FKZ 81Z0400101"],"award-info":[{"award-number":["DZHK\/FKZ 81Z0400101"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG060499-01"],"award-info":[{"award-number":["R01 AG060499-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AG071717-01A1"],"award-info":[{"award-number":["R01 AG071717-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21HL145217"],"award-info":[{"award-number":["R21HL145217"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AG063893"],"award-info":[{"award-number":["U19AG063893"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61 HL155858"],"award-info":[{"award-number":["R61 HL155858"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jacadv.2025.102183","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:54:04Z","timestamp":1760075644000},"page":"102183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P1","title":["Plasma Ceramide C24:0\/C16:0 Relates to Outcomes in Patients With Heart Failure With Preserved Ejection Fraction"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8766-4552","authenticated-orcid":false,"given":"Linda R.","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuntian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Campbell","family":"Heurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Province","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Cresci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2025.102183_bib1","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118(17)","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacadv.2025.102183_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","article-title":"The emerging epidemic of heart failure with preserved ejection fraction","volume":"10","author":"Oktay","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jacadv.2025.102183_bib3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102183_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102183_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018574","article-title":"Sex differences in heart failure with preserved ejection fraction","volume":"10","author":"Sotomi","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2025.102183_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","article-title":"Myocardial gene expression signatures in human heart failure with preserved ejection fraction","volume":"143","author":"Hahn","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102183_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ahj.2015.12.020","article-title":"Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise testing (FIT-CPX) project","volume":"174","author":"Shafiq","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacadv.2025.102183_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10741-011-9249-z","article-title":"The paradox of low BNP levels in obesity","volume":"17","author":"Clerico","year":"2012","journal-title":"Heart Fail Rev"},{"issue":"8","key":"10.1016\/j.jacadv.2025.102183_bib9","first-page":"256","article-title":"Biomarkers of HFpEF: natriuretic peptides, high-sensitivity troponins and beyond","volume":"9","author":"Morfino","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"issue":"10","key":"10.1016\/j.jacadv.2025.102183_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007931","article-title":"Ceramide remodeling and risk of cardiovascular events and mortality","volume":"7","author":"Peterson","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacadv.2025.102183_bib11","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.1210\/jc.2013-2559","article-title":"Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency","volume":"99","author":"Tarasov","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacadv.2025.102183_bib12","series-title":"Sphingolipids and metabolic diseases","first-page":"1","article-title":"Sphingolipid metabolism and analysis in metabolic disease","author":"Brice","year":"2011"},{"key":"10.1016\/j.jacadv.2025.102183_bib13","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1007\/s00216-013-7166-9","article-title":"Development and validation of LC-MS\/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma","volume":"405","author":"Jiang","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jacadv.2025.102183_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacadv.2025.102183_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.12997\/jla.2020.9.1.172","article-title":"Genetic architecture of circulating very-long-chain (C24:0 and C22:0) ceramide concentrations","volume":"9","author":"Cresci","year":"2020","journal-title":"J Lipid Atheroscler"},{"key":"10.1016\/j.jacadv.2025.102183_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112629","article-title":"Natriuretic peptides in heart failure with preserved left ventricular ejection fraction: from molecular evidences to clinical implications","volume":"20","author":"Tanase","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacadv.2025.102183_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.15420\/cfr.2018.26.1","article-title":"Natriuretic peptides in chronic heart failure","volume":"5","author":"Brunner-La Rocca","year":"2019","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.jacadv.2025.102183_bib18","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.110.981431","article-title":"Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum","volume":"123","author":"De Keulenaer","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacadv.2025.102183_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2020.11.066","article-title":"Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction","volume":"327","author":"Sakane","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacadv.2025.102183_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12967-021-02735-3","article-title":"Biomarker profiling for risk of future heart failure (HFpEF) development","volume":"19","author":"Watson","year":"2021","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.jacadv.2025.102183_bib21","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDctcs2100007","article-title":"Behind the scenes of TOPCAT \u2013 bending to inform","volume":"1","author":"Pfeffer","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jacadv.2025.102183_bib22","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/j.jacc.2020.02.062","article-title":"Circulating ceramide 16:0 in heart failure with preserved ejection fraction","volume":"75","author":"Javaheri","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2025.102183_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005708","article-title":"Plasma ceramides and sphingomyelins in relation to heart failure risk","volume":"12","author":"Lemaitre","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jacadv.2025.102183_bib24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ijcard.2016.06.080","article-title":"Heart failure hospitalization: an important prognostic factor for heart failure re-admission and mortality","volume":"220","author":"Ruig\u00f3mez","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacadv.2025.102183_bib25","first-page":"157","article-title":"Burden of hospitalization for heart failure in the United States: a systematic literature review","volume":"28","author":"Osenenko","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.jacadv.2025.102183_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/acn3.50973","article-title":"Circulating ceramide ratios and risk of vascular brain aging and dementia","volume":"7","author":"McGrath","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"10.1016\/j.jacadv.2025.102183_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.82922","article-title":"Increased de novo ceramide synthesis and accumulation in failing myocardium","volume":"2","author":"Ji","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jacadv.2025.102183_bib28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MOL.0000000000000802","article-title":"Links between ceramides and cardiac function","volume":"33","author":"Park","year":"2022","journal-title":"Curr Opin Lipidol"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X2500609X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X2500609X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T12:33:23Z","timestamp":1778934803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X2500609X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2772963X2500609X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102183","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Ceramide C24:0\/C16:0 Relates to Outcomes in Patients With Heart Failure With Preserved Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2025.102183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"102183"}}